A $25 million V-prize

Virgin's millions are up for grabs. What's a biologist to do? Tycoon Richard Branson offered another $25 million to combat global warming (he pledged $3 billion in September). This time he's taking a page from X-prize folks, offering the money as a prize for the best design of a plan for removing ?significant volumes of anthropogenic, atmospheric greenhouse gases.? Although the official rules are a bit hazy on what a ?significant amount? means (they are far less hazy on publicity rights and s

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Virgin's millions are up for grabs. What's a biologist to do? Tycoon Richard Branson offered another $25 million to combat global warming (he pledged $3 billion in September). This time he's taking a page from X-prize folks, offering the money as a prize for the best design of a plan for removing ?significant volumes of anthropogenic, atmospheric greenhouse gases.? Although the official rules are a bit hazy on what a ?significant amount? means (they are far less hazy on publicity rights and several other items), reports are generalizing the target to a billion tons or more yearly. Enrollment is open for three years, after which entries will be judged by none other than Al Gore. It will be interesting to see what comes of this. And I for one would like to see some imaginative biologists take this. So far, engineered algal blooms and genetically modified trees designed to sequester carbon in their roots are interesting, but I don?t think they're going to tip the scales at a billion tons a year. What's your idea?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies